Ruiz-Moreno, José Maria <br/><br/>
Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.  [electronic resource] 

 -  Retina (Philadelphia, Pa.)   
 - 602-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0275-004X 
<br/><br/><label>Standard No.: </label>10.1097/01.iae.0000224942.59481.c9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Choroidal Neovascularization--drug therapy<br/>Drug Therapy, Combination<br/>Exudates and Transudates<br/>Female<br/>Fluorescein Angiography<br/>Follow-Up Studies<br/>Glucocorticoids--administration & dosage<br/>Humans<br/>Injections<br/>Macular Degeneration--complications<br/>Male<br/>Middle Aged<br/>Photochemotherapy<br/>Photosensitizing Agents--therapeutic use<br/>Porphyrins--therapeutic use<br/>Prospective Studies<br/>Retreatment<br/>Triamcinolone Acetonide--administration & dosage<br/>Verteporfin<br/>Visual Acuity<br/>Vitreous Body--drug effects